Xiaofeng He

Chengdu, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Case Report: Primary intracranial high-grade myofibroblastic sarcoma and literature review.

Case Report: Primary intracranial high-grade myofibroblastic sarcoma and literature review.

Journal: Frontiers in oncology
Published: December 20, 2024

Comparative bioactivity evaluation and metabolic profiling of different parts of Duhaldea nervosa based on GC-MS and LC-MS.

Comparative bioactivity evaluation and metabolic profiling of different parts of Duhaldea nervosa based on GC-MS and LC-MS.

Journal: Frontiers in nutrition
Published: September 25, 2023

Adjuvant Chemoradiotherapy for Gastric Cancer: Efficacy and Cost-Effectiveness Analysis.

Adjuvant Chemoradiotherapy for Gastric Cancer: Efficacy and Cost-Effectiveness Analysis.

Journal: Frontiers in oncology
Published: October 13, 2019

Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study.

Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study.

Journal: Medicine
Published: October 07, 2018

MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.

MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.

Journal: Yonsei medical journal
Published: August 28, 2018

Factors related to the receipt of adjuvant therapy among patients with gastric cancer in Western China.

Factors related to the receipt of adjuvant therapy among patients with gastric cancer in Western China.

Journal: European journal of cancer care
Published: November 27, 2017

Cost-effectiveness of sorafenib as a first-line treatment for advanced hepatocellular carcinoma.

Cost-effectiveness of sorafenib as a first-line treatment for advanced hepatocellular carcinoma.

Journal: European journal of gastroenterology & hepatology
Published: April 29, 2015

Which is false: oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody.

Which is false: oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody.

Journal: Cancer science
Published: May 13, 2013

Cost analysis of S1 and XELOX as adjuvant therapy for gastric cancer.

Cost analysis of S1 and XELOX as adjuvant therapy for gastric cancer.

Journal: Anti-cancer drugs
Published: May 01, 2013
Showing 1-9 of 9

Last Updated: 09/26/2026